DE102007057543A1 - a-Aminosäurederivate zur Löslichkeitsverbesserung - Google Patents

a-Aminosäurederivate zur Löslichkeitsverbesserung Download PDF

Info

Publication number
DE102007057543A1
DE102007057543A1 DE102007057543A DE102007057543A DE102007057543A1 DE 102007057543 A1 DE102007057543 A1 DE 102007057543A1 DE 102007057543 A DE102007057543 A DE 102007057543A DE 102007057543 A DE102007057543 A DE 102007057543A DE 102007057543 A1 DE102007057543 A1 DE 102007057543A1
Authority
DE
Germany
Prior art keywords
branched
chain
straight
groups
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102007057543A
Other languages
German (de)
English (en)
Inventor
Thomas Dr. Rudolph
Michaela Klante
Herwig Dr. Buchholz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to DE102007057543A priority Critical patent/DE102007057543A1/de
Priority to JP2010535285A priority patent/JP2011504891A/ja
Priority to PCT/EP2008/010045 priority patent/WO2009068275A2/de
Priority to US12/745,143 priority patent/US8293784B2/en
Priority to EP08853958A priority patent/EP2211827A2/de
Publication of DE102007057543A1 publication Critical patent/DE102007057543A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26—Optical properties
    • A61K2800/262—Transparent; Translucent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous
DE102007057543A 2007-11-29 2007-11-29 a-Aminosäurederivate zur Löslichkeitsverbesserung Withdrawn DE102007057543A1 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE102007057543A DE102007057543A1 (de) 2007-11-29 2007-11-29 a-Aminosäurederivate zur Löslichkeitsverbesserung
JP2010535285A JP2011504891A (ja) 2007-11-29 2008-11-27 溶解性を改良するためのα−アミノ酸誘導体
PCT/EP2008/010045 WO2009068275A2 (de) 2007-11-29 2008-11-27 α-AMINOSÄUREDERIVATE ZUR LÖSLICHKEITSVERBESSERUNG
US12/745,143 US8293784B2 (en) 2007-11-29 2008-11-27 α-amino acid derivatives for improving solubility
EP08853958A EP2211827A2 (de) 2007-11-29 2008-11-27 Alpha-aminosäurederivate zur löslichkeitsverbesserung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007057543A DE102007057543A1 (de) 2007-11-29 2007-11-29 a-Aminosäurederivate zur Löslichkeitsverbesserung

Publications (1)

Publication Number Publication Date
DE102007057543A1 true DE102007057543A1 (de) 2009-06-04

Family

ID=40377294

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102007057543A Withdrawn DE102007057543A1 (de) 2007-11-29 2007-11-29 a-Aminosäurederivate zur Löslichkeitsverbesserung

Country Status (5)

Country Link
US (1) US8293784B2 (US20110039924A1-20110217-C00022.png)
EP (1) EP2211827A2 (US20110039924A1-20110217-C00022.png)
JP (1) JP2011504891A (US20110039924A1-20110217-C00022.png)
DE (1) DE102007057543A1 (US20110039924A1-20110217-C00022.png)
WO (1) WO2009068275A2 (US20110039924A1-20110217-C00022.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2906547B2 (en) * 2012-10-12 2022-10-26 L'Oréal Cosmetic compositions containing at least one hydrotrope and at least one active compound
CN105963244A (zh) * 2016-01-15 2016-09-28 赵鸣 注射用青蒿琥酯制剂及其应用
JP7194517B2 (ja) * 2017-05-30 2022-12-22 花王株式会社 皮膚化粧料
CN110785161B (zh) 2017-06-23 2023-06-20 宝洁公司 用于改善皮肤外观的组合物和方法
WO2020010036A1 (en) 2018-07-03 2020-01-09 The Procter & Gamble Company Method of treating a skin condition
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
WO2021247496A1 (en) 2020-06-01 2021-12-09 The Procter & Gamble Company Method of improving penetration of a vitamin b3 compound into skin

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4116123A1 (de) 1991-05-17 1992-11-19 Chem & Pharm Patent Hold Ltd Mittel zur behandlung von hauterkrankungen
DE4308282A1 (de) 1993-03-16 1994-09-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
WO2000009652A2 (en) 1998-08-13 2000-02-24 Sol-Gel Technologies Ltd. Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof
WO2000071084A1 (en) 1999-05-25 2000-11-30 Sol-Gel Technologies Ltd A method for obtaining photostable sunscreen compositions
WO2000072806A2 (en) 1999-05-26 2000-12-07 Sol-Gel Technologies Ltd Sunscreen composition containing sol-gel microcapsules
US6242099B1 (en) 1996-11-21 2001-06-05 Merck S.A. Microcapsules made of chitin or of chitin derivatives containing a hydrophobic substance, in particular a sunscreen, and process for the preparation of such microcapsules
DE10133202A1 (de) 2001-07-07 2003-01-16 Beiersdorf Ag Osmolyte enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
DE10232595A1 (de) 2002-07-18 2004-02-05 Merck Patent Gmbh Lichtschutzmittel
DE10244282A1 (de) 2002-09-23 2004-04-01 Merck Patent Gmbh Zubereitung mit antioxidanten Eigenschaften

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4980165A (en) 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
JPH05301813A (ja) * 1991-10-15 1993-11-16 Kao Corp 皮膚外用剤
CH685561A5 (de) 1992-01-27 1995-08-15 Polygon Chemie Ag Verwendung von von beta-Alanin und dessen Homologen abgeleiteten Tensiden zur Verbesserung der Wasserlöslichkeit von Farbstoffen und optischen Aufhellern.
CA2323364A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Compositions for regulating skin appearance
DE10014632A1 (de) 2000-03-24 2001-09-27 Merck Patent Gmbh Verwendung von Ectoin oder Ectoin-Derivaten zum Schutz der Streßproteine in der Haut
ES2320103T3 (es) * 2001-06-26 2009-05-19 L'oreal Composiciones que comprenden un compuesto de baja solubilidad y un derivado lipofilo de acido aminado, utilizaciones y procedimientos correspondientes.
US6844303B2 (en) * 2001-12-14 2005-01-18 Rainer Lange Cleaning compositions and their use in feminine hygiene wipes
DE10240923A1 (de) * 2002-09-02 2004-03-04 Merck Patent Gmbh Flavonoid-Derivate zur Ekzem-Behandlung
DE10247357A1 (de) 2002-10-10 2004-04-22 Beiersdorf Ag Fettfreie Sonnenschutzmittel
CA2528101C (fr) * 2002-12-30 2012-01-31 Jean-Noel Thorel Bio-activateur metabolique cutane
DE10316666B4 (de) * 2003-04-10 2015-04-09 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin mit Kreatin und Coenzym Q10
DE102004002787A1 (de) * 2004-01-19 2005-08-11 Merck Patent Gmbh Flavonoid-Komplexe
JP5241054B2 (ja) * 2004-02-27 2013-07-17 ロート製薬株式会社 コラーゲン合成促進用組成物
JP2005298452A (ja) * 2004-04-16 2005-10-27 Saga Seiyaku Kk アズレン誘導体含有の水性液剤の安定化法
JP3878629B2 (ja) * 2004-08-04 2007-02-07 ピアス株式会社 複合化水性ゲルとその製造方法、並びに、その複合化水性ゲルを含有するゲル化製剤、皮膚外用剤、及び化粧料
DE202005011885U1 (de) 2005-07-28 2006-08-31 Schwan-Stabilo Cosmetics Gmbh & Co. Kg Geschäumte Zubereitung
DE102006037724A1 (de) 2006-08-11 2008-02-14 Merck Patent Gmbh Verwendung von Ascorbinsäurederivaten zur Funktionalisierung von Matrices

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4116123A1 (de) 1991-05-17 1992-11-19 Chem & Pharm Patent Hold Ltd Mittel zur behandlung von hauterkrankungen
DE4308282A1 (de) 1993-03-16 1994-09-22 Beiersdorf Ag Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
US6242099B1 (en) 1996-11-21 2001-06-05 Merck S.A. Microcapsules made of chitin or of chitin derivatives containing a hydrophobic substance, in particular a sunscreen, and process for the preparation of such microcapsules
WO2000009652A2 (en) 1998-08-13 2000-02-24 Sol-Gel Technologies Ltd. Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof
WO2000071084A1 (en) 1999-05-25 2000-11-30 Sol-Gel Technologies Ltd A method for obtaining photostable sunscreen compositions
WO2000072806A2 (en) 1999-05-26 2000-12-07 Sol-Gel Technologies Ltd Sunscreen composition containing sol-gel microcapsules
DE10133202A1 (de) 2001-07-07 2003-01-16 Beiersdorf Ag Osmolyte enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
DE10232595A1 (de) 2002-07-18 2004-02-05 Merck Patent Gmbh Lichtschutzmittel
DE10244282A1 (de) 2002-09-23 2004-04-01 Merck Patent Gmbh Zubereitung mit antioxidanten Eigenschaften

Also Published As

Publication number Publication date
JP2011504891A (ja) 2011-02-17
US20110039924A1 (en) 2011-02-17
WO2009068275A2 (de) 2009-06-04
US8293784B2 (en) 2012-10-23
WO2009068275A3 (de) 2010-09-23
EP2211827A2 (de) 2010-08-04

Similar Documents

Publication Publication Date Title
EP2170253B1 (de) Uv-filter-kapsel
EP1965639B1 (de) Insektenabwehrmittel mischung
DE102007013368A1 (de) Verwendung einer Mischung eines Selbstbräuners mit einem Formaldehydfänger
EP2004136B1 (de) Verwendung von Flavonoiden
WO2005074897A2 (de) Formulierungshilfsmittel (aminopropansäure derivative) in kosmetischen oder dermatologischen zubereitungen
DE102008031480A1 (de) Salze enthaltend ein Pyrimidincarbonsäure-Derivat
WO2006018104A1 (de) Uv-filter
EP1720510B1 (de) Uv-filter in puderform
DE102005013380A1 (de) Extraktionsverfahren
DE102007057543A1 (de) a-Aminosäurederivate zur Löslichkeitsverbesserung
DE102006006413A1 (de) UV-Filter-Kapsel
EP1527777A1 (de) Zubereitung mit antioxidanten Eigenschaften, die einen Benzoesäureester der Ascorbinsäure enthält
DE102004038728A1 (de) Flavonoid-Komplexe
EP1934188B1 (de) Alpha, alpha`-dihydroxyketonderivate und deren verwendung als uv-filter
DE102005015446A1 (de) Synergisten zur Verstärkung der Wirkung von Repellentien
EP1909919B1 (de) Flavonoide als synergisten zur verstärkung der wirkung von selbstbräunungssubstanzen
DE102005011534A1 (de) Chromen-4-on-Derivate
DE102004011111A1 (de) Formulierung zur Stabilisierung von UV-Filtern
DE102007041854A1 (de) Bifunktionelle DHA-Derivate
DE102004025372A1 (de) Verwendung von Effektpigmenten
DE102005058542A1 (de) Erythruloseester als UV Filter
DE102004045482A1 (de) UV-Filter-Mischung

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee